Ryan Scott

Brittney Nichols highlights the need for early detection and stresses that lung cancer is not only caused by smoking; anyone can develop the disease.

Dr. Ravi Munver discusses how minimally invasive techniques allow patients to preserve kidney function and practical guidance for navigating treatment.

This guide provides a supportive overview of stage 2 melanoma, covering diagnosis, treatment options, and key questions for your medical team.

Jennie Smythe continues the conversation following her initial discussion on early detection self-advocacy during Breast Cancer Awareness Month.

Young women with breast cancer experience significant declines in body image, sexual satisfaction, and sexual interest both during and after treatment.

Although death rates continue to decline each year, prostate cancer cases are increasing, especially those diagnosed at advanced stages.

As we approach Lung Cancer Awareness Month this November, it’s important to reflect on the latest developments and insights in lung cancer research.

October is Breast Cancer Awareness Month, and CURE is here to address some of the most common questions patients have after a breast cancer diagnosis.

As we kick off Breast Cancer Awareness Month, it’s an opportune time to reflect on some of the most important breast cancer stories shared last month.

As September concludes, the landscape of GU oncology continues to evolve, with important developments in prostate, bladder, kidney and other cancers.

This guide on stage 2 kidney cancer covers key info, treatments and what to expect, helping you prepare for informed discussions with your care team.

Recent clinical trial results, real-world safety data, and patient experiences highlight meaningful advances in blood cancer care.

Jennie Smythe, a breast cancer survivor, shared her journey from diagnosis to survivorship in an interview with CURE during Breast Cancer Awareness Month.

The FDA approved the denosumab biosimilars Enoby and Xtrenbo for patients on hormone therapies for breast or prostate cancer that weaken bones.

Tamara Mobley shares how persistent back pain led to her myeloma diagnosis and why she now raises awareness to help others recognize subtle warning signs.

Cancer during pregnancy is rare but increasingly recognized as maternal age rises and non-invasive prenatal testing becomes more common.

Lymphoma is a treatable cancer of the immune system; early diagnosis and personalized treatment with chemo and radiation often lead to a cure.

The FDA granted priority review to an sBLA for first-line treatment with Enhertu plus Perjeta in unresectable or metastatic HER2-positive breast cancer.

Dr. Ravi Munver sat down for an interview with CURE to discuss progress in kidney cancer care.

The U.S. FDA has granted fast track designation to the investigational therapy MNV-201 for the treatment of myelodysplastic syndrome.

The FDA has granted approval to subcutaneous Keytruda for use in adults and pediatric patients with a solid tumor.

Leukemia is a blood cancer that disrupts normal cell production, leading to infection risk, anemia and bleeding, and requiring tailored treatments.

The FDA approved Bosaya and Aukelso, biosimilars of Prolia and Xgeva, respectively, for the treatment of solid tumors, like breast and prostate cancer.

Researchers have created a novel immunotherapy for metastatic kidney cancer that could provide a new treatment option for patients with limited options.

Bob Lane, a prostate cancer survivor, discusses the stigma men often feel when talking about prostate cancer.

Dr. Prithviraj Bose explains how doctors tailor myelofibrosis treatments and how patients can work with their care teams to navigate options.

The FDA has granted fast track designation to the investigational drug CRB-701 for recurrent or metastatic head and neck squamous cell carcinoma.

Early-stage gynecologic cancer is confined to its original site and often treatable; diagnosis, surgery, and new therapies improve outcomes.

Your diagnosis of an early-stage blood cancer, such as a MPN or MDS, means that something has changed in the way your bone marrow produces blood cells.

GLP-1a treatment in patients with polycythemia vera was linked to significant reductions in mortality, disease progression, and serious complications.